![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20750-20755, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 27, 2002, and in revised form, March 29, 2002
Protein serine/threonine phosphatase (PP) 2A is a
ubiquitous enzyme with pleiotropic functions. Trimeric PP2A consists of a structural A subunit, a catalytic C subunit, and a variable regulatory subunit. Variable subunits (B, B', and B" families) dictate
PP2A substrate specificity and subcellular localization. B-family
subunits contain seven WD repeats predicted to fold into a
The balance of protein kinase and phosphatase activities toward
key proteins is central to many aspects of cellular physiology. Compared with kinases, protein phosphatases have received little attention, and appreciation that they may be just as precisely regulated as the enzymes whose action they oppose is relatively recent.
PP2A1 is one of the four
major classes of serine/threonine phosphatases that also include PP1,
PP2B (calcineurin), and PP2C. PP2A is highly conserved in eukaryotes
(for recent reviews, see Refs. 1 and 2). It constitutes between 0.3%
and 1% of total protein in mammalian cells (3, 4) and supplies the
majority of soluble phosphatase activity toward phospho-serine and
-threonine. PP2A is a holoenzyme of two or three subunits. A 36-kDa
catalytic or C subunit complexes with a 65-kDa scaffolding A subunit to form the AC core enzyme; the core enzyme can bind a third, variable subunit to form the PP2A heterotrimer. In mammals, A and C subunits are
each encoded by two highly similar genes (A Evidence is accumulating that regulatory subunits impart specific
functions to PP2A holoenzymes (24, 25). For example, B-family
regulatory subunits have been implicated in the regulation of
cytoskeletal protein assembly (26-28), B' subunits participate in the
developmental Wnt/ The crystal structure of the scaffolding A Knowing how regulatory subunits fold and interact with the core PP2A
dimer is crucial for our understanding of the diverse roles of PP2A in
cells. Here, we carry out deletion and site-directed mutagenesis in
combination with structure modeling to identify domains and amino acids
important for holoenzyme association of B-family regulatory subunits.
By complementary charge-reversal mutagenesis, we show that adjacent
arginines in B Structure Modeling--
An amino acid alignment of B-family
regulatory subunits from different phyla was submitted to the 3D-PSSM
protein fold recognition web server (39), which generated a first-round
model based on the structure of the G Mutagenesis--
The rat cDNA for B
The B
Generation of internal deletion mutants involved PCR amplification of
two halves of the B
The B Transfection and Immunoprecipitation--
COS-M6 cells (43) were
cultured in Dulbecco's modified Eagle's medium containing 10% fetal
bovine serum and 4.5 g/liter glucose and seeded into 6-well plates for
transfection on the next day at ~80% confluence. Cells were
transfected with 4 µl of LipofectAMINE 2000 (Invitrogen) and 2 µg
of plasmid DNA. A Structure Prediction of PP2A B-family Regulatory
Subunits--
Mammalian B-family regulatory PP2A subunits (B
The two WD repeat-containing proteins whose three-dimensional structure
has been solved to date are the G
Three web-based threading protein fold prediction algorithms (3D-PSSM
(39), FUGUE (47), and 123D (genomic.sanger.ac.uk/123D/123D.html)) identified G Deletion Mutagenesis--
To define regions and residues in
B-family regulatory subunits critical for association with the AC core
dimer, we carried out deletion and site-directed mutagenesis of the
B
B subunit family members differ considerably in their first 20-30
residues. Deletion of the variable 20 N-terminal amino acids of B
At the C terminus, truncating the 8 amino acids that follow the last WD
repeat in B
Four internal deletions throughout the B Charge-reversal Mutagenesis--
Site-directed mutagenesis was
carried out to delineate specific sites of holoenzyme interaction. All
B
Three acidic-to-basic mutations of conserved residues in the N-terminal
third of B
The results of the deletion and site-directed mutagenesis experiments
are summarized in Fig. 3B. B
Li and Virshup (48) have recently reported that two fragments of B' Identification of Interacting Residues--
We speculated that
evolutionarily conserved and surface-exposed, charged residues of B
However, when we paired A Monomeric B
It was previously shown that transfected B' subunits quantitatively
incorporate into the PP2A holoenzyme (11) and that ablation of PP2A A
or C subunits by RNA interference decreases the stability of regulatory
subunits in Drosophila Schneider cells (25). The present
results provide further evidence that PP2A subunit expression levels
are stringently controlled in cells and suggest ubiquitination and
proteasome-mediated degradation as a mechanism for rapid removal of
monomeric regulatory subunits.
Structure modeling and site-directed mutagenesis support the model of
PP2A holoenzyme structure shown in Fig.
6. B-family regulatory subunits adopt a
We thank Nancy Lill for advice on the
proteasome experiments and gifts of MG-132 and ubiquitin antibody,
Henry Paulson for PC6-3 cells, Raul Dagda for technical assistance, and
John Koland for comments on the manuscript.
*
This work was supported by funds from the Department of
Pharmacology and the Biosciences Initiative of the University of Iowa and by seed grants from the Diabetes and Endocrinology Research Center
(DK25295) and the College of Medicine.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
University of Iowa College of Medicine, 2-432 BSB, 51 Newton Rd., Iowa
City, IA 52242. Tel.: 319-384-4439; Fax: 319-335-8930; E-mail:
stefan-strack@uiowa.edu.
Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.M202992200
The abbreviation used is:
PP, protein
serine/threonine phosphatase.
Protein Phosphatase 2A Holoenzyme Assembly
IDENTIFICATION OF CONTACTS BETWEEN B-FAMILY REGULATORY AND
SCAFFOLDING A SUBUNITS*
§,
,
, and
Department of Pharmacology, University of
Iowa, Iowa City, Iowa 52242 and ¶ Department of Pathology,
University of California at San Diego, La Jolla, California 92093
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-propeller structure. We carried out mutagenesis of B
to identify domains important for association with A and C subunits in
vivo. Several internal deletions in B
abolished
coimmunoprecipitation of A and C subunits expressed in COS-M6 cells. In
contrast, small N- and C-terminal B
deletions had no effect on
incorporation into the PP2A heterotrimer. Thus, holoenzyme association
of B-family subunits requires multiple, precisely aligned contacts
within a core
-propeller domain. Charge-reversal mutagenesis of B
identified a cluster of conserved critical residues in B
WD repeats
3 and 4. Acidic substitution of paired basic residues in B
(RR165EE) abolished association with wild-type A and C subunits, while fostering incorporation of B
into a PP2A heterotrimer containing an A subunit with an opposite charge-reversal mutation (EE100RR). Thus, binding of A
and B subunits requires electrostatic interactions between conserved
pairs of glutamates and arginines. By expressing complementary charge-reversal mutants in neuronal PC6-3 cells, we further show that
holoenzyme incorporation protects B
from rapid degradation by the
ubiquitin/proteasome pathway.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
/
and C
/
), with
A
and C
isoforms being more abundant. Regulatory subunits are
encoded by three multigene families referred to as B, B', and B". The B
family (also known as PR55) consists of four genes, B
, B
, B
,
and B
, that give rise to proteins with molecular masses of 54-57
kDa (5-9). The B' family (also referred to as B56 or PR61) consists of
at least seven isoforms encoded by five genes (B'
, B'
, B'
,
B'
, and B'
) (10-15), with molecular masses between 54 and 74 kDa. The four known members of the B" family are designated according
to their masses as PR48 (16), PR59 (17), and PR72/130 (18). Several
PP2A regulatory subunits show restricted tissue expression; for
instance, B
and B
can only be detected in brain (6, 19). Proteins
encoded by DNA tumor viruses, SV40 small t and polyoma virus small and
middle T antigen, are a fourth group of proteins that bind to the PP2A core enzyme and subvert its activity as a suppressor of cellular transformation (20-22). The AC dimer has also been shown to interact with other proteins, including the WD repeat-containing proteins striatin and SG2NA (23).
-catenin signal transduction cascade (29, 30), and
B" subunits may control the G1-S cell cycle transition (16,
17). Adenovirus type 5 appears to induce apoptosis by interaction of
its E4orf4 protein with the B
subunit of PP2A (31, 32). How
regulatory subunits function to mediate the diverse physiological
functions of PP2A is poorly understood. There is in vitro
evidence that regulatory subunits affect enzymatic activity and
substrate specificity of PP2A (33). Localization studies have suggested
that regulatory subunits target PP2A holoenzymes to distinct
subcellular compartments (11, 14, 19).
subunit of PP2A has been
solved (34), confirming a previous model based on secondary structure
prediction and mutagenesis studies (35). The A subunit is a hook-shaped
protein made up almost entirely of 15 imperfect repeats, each about 40 amino acids long. Each of these HEAT repeats (named after proteins that
contain them: huntingtin, elongation factor,
A subunit, and TOR kinase) consists of two
antiparallel, amphipathic
-helices. Loops between the two helices
(intrarepeat loops) form a continuous ridge along the inside of the
hook, providing interaction surfaces for catalytic and regulatory
subunits. Regulatory subunits and viral antigens bind to the 10 N-terminal repeats, whereas the catalytic subunit binds via repeats
11-15 (35, 36). The PP2A C subunit is thought to have a roughly
globular structure similar to that of the related PP1 C subunit (37,
38).
critically interact with adjacent glutamates in the
A
subunit.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1 subunit of heterotrimeric G
proteins (40). This model was globally and locally optimized for bond lengths, angles, and torsions of side chains using the steepest decent
algorithm of the Swiss PDB Viewer software (41). In addition, breaks in the C
trace were ligated with a cutoff value
of 3.0 Å, and missing hydrogen atoms were added to the model. Ribbon diagrams and surface representations of the optimized B subunit model
were rendered, annotated, and analyzed using Rasmol and Swiss PDB
Viewer software.
was isolated by
reverse transcription-PCR from rat brain total RNA (Access reverse
transcription-PCR kit; Promega, Madison, WI), subcloned into a
pcDNA3.1 mammalian expression vector under control of the
cytomegalovirus promoter, and FLAG epitope tagged at the N terminus by PCR.
26-38 and
379-447 mutants were generated by
restriction digestion of the wild-type plasmid with uniquely cutting restriction enzymes, followed by fill-in and recircularization reactions. The B
1-20 N-terminal truncation mutant was generated by PCR amplification of the coding sequence with nested primers encoding the FLAG tag and amino acids 21-25 of B
.
cDNA-containing plasmid, one extending from
the 5' end of the deletion to approximately halfway around the plasmid,
and the other extending from the 3' deletion boundary to the same site
in the vector backbone in the opposite direction. Reverse primers
annealing to sequences 5' of the deletion and forward primers annealing
to 3' deletion boundaries also included a unique SacII site
encoding a neutral "stuffer" sequence (Ala, Ala-Ala, or
Ala-Ala-Gly), and complementary forward and reverse primers annealing
to the plasmid backbone introduced a unique AscI site.
PCR-generated plasmid halves were digested with SacII and
AscI and ligated to produce the complete plasmid carrying the deletion.
434-447 and
440-447 C-terminal truncation mutants were
generated by site-directed mutagenesis of residues 434 and 440, respectively, to termination codons. Site-directed mutagenesis was
carried out by whole-plasmid synthesis with complementary primers
harboring mutations utilizing Pfu Turbo polymerase
(Stratagene), followed by destruction of the template plasmid by
digestion with DpnI. All mutations were verified by
automated sequencing. All A
subunit plasmids have been described
previously (42).
and B
subunits plasmids were cotransfected at
1:1 mass ratios. After 36-48 h, cells were rinsed once with
phosphate-buffered saline, lysed in 250 µl/well immunoprecipitation
buffer (1% Triton X-100, 150 mM NaCl, 20 mM
Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM
-glycerolphosphate, 1 mM
Na3VO4, 1 mM
Na4P2O7, 1 µM
microcystin-LR, 1 mM phenylmethylsufonyl fluoride, 1 µg/ml leupeptin, and 1 mM benzamidine), and sonicated for
2 s at low intensity with a probe tip sonicator. Debris was
pelleted (20,000 × g, 15 min), and FLAG-tagged B
subunits were immunoprecipitated from the cleared lysate with 6 µl of
anti-FLAG tag antibody (M2) conjugated to agarose (Sigma) by
end-over-end rotation at 4 °C for 3-16 h. In some experiments, 200 µg/ml FLAG epitope peptide was added to the cleared lysate as a
specificity control. Immunoprecipitates were washed with 6-8 ml of
immunoprecipitation buffer and solubilized in SDS sample buffer for
immunoblot analysis using the following antibodies: rabbit anti-FLAG
tag (Affinity Bioreagents, Golden, CO), mouse anti-EE tag (Babco,
Richmond, CA), mouse anti-PP2A catalytic subunit (BD PharMingen), and
rabbit anti-ubiquitin (Novocastra, Newcastle, UK). Blots were processed
for chemiluminescence detection (Pierce SuperSignal, Pierce, New York,
NY), and digital images were captured on a Kodak Imaging Station 440. Signal intensities were quantified by digital densitometry
using National Institutes of Health Image software
(rsb.info.nih.gov/nih-image/).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-
)
display high degrees of sequence conservation (>80% amino acid
identity). Secondary structure prediction suggests that B-family
regulatory subunits are almost entirely composed of
-sheets and
turns, whereas the B' and B" subunits are mostly
-helical. Thus,
PP2A regulatory subunit families have distinct primary and secondary
structures. As has been noted previously (44), B-family regulatory
subunits contain several degenerate WD repeats (four to seven,
depending on the isoform and motif search threshold). WD (also called
WD40 or G
) repeats are loosely defined, ~40-amino acid sequence
motifs that often end with the tryptophan-aspartate (WD) dipeptide
(45). The amino acid sequence of B
, a representative member of the B
subunit family, aligned by WD repeat motifs is shown in Fig. 1A. Seven degenerate WD
repeats are separated by regions of 13-46 residues in length (c-d
loops).

View larger version (40K):
[in a new window]
Fig. 1.
Structure prediction of B-family regulatory
subunits. A, the amino acid sequence of B
was
aligned according to boundaries of the seven WD repeats and component
-strands (d and a
c) provided by the Pfam web
application (pfam.wustl.edu; Ref. 54). Sequence conservation of WD
repeats is indicated by gray and black shading.
B, schematic of
-strand arrangement of the
-propeller
fold, highlighting the phase-shift of WD repeats (identified by
shading) and propeller blades. C, ribbon view of
the B subunit model based on the G
1 crystal structure; note that the
large loops connecting WD repeats (c-d loops) were not
completely modeled.
1 subunit of heterotrimeric G
proteins (40) and the p40 subunit of the arp2/3 actin filament branching complex (p40-ARC; Ref. 46). Both proteins fold into a
seven-bladed
-propeller, a toroid structure in which seven twisted,
antiparallel
-sheets are radially arranged around a common center.
Each WD repeat contributes the outer (d)
-strand of one propeller
blade and the inner three
-strands (a
c) of the next propeller
blade (Fig. 1B). This phase-shift of sequence and structural
motifs allows for closure of the torus by a "velcro" mechanism
(45). Sequences preceding the first WD repeat and trailing the last
repeat may protrude from the core toroid (Fig. 1B).
1 as the closest structural homolog of PP2A B-family regulatory subunits, despite low sequence similarity (~15%
identity). The structure of B-family regulatory subunits was modeled
based on the G
1 crystal structure (see "Experimental
Procedures"). A ribbon diagram of this model shows the seven-bladed
-propeller fold characteristic of WD repeat-containing proteins
(Fig. 1C). Because PP2A B-family regulatory subunits are
larger than G
1, portions of the larger loops connecting WD repeats
are missing from the model.
coding sequence. Mutant B
cDNAs carrying an N-terminal FLAG
epitope tag were transiently expressed in COS-M6 cells in combination
with the scaffolding A
subunit tagged with a C-terminal EE epitope
(42). FLAG-B
was immunoprecipitated and washed extensively, and
in vivo incorporation into the PP2A heterotrimer was assayed
by blotting B
immunoprecipitates for transfected A
and endogenous
C subunits. The ability of B
mutants to associate with the core
enzyme was quantified by densitometry as the ratio of C to B
subunit
bands in the same lane. In general, mutating B
affected A
and C
subunit binding to similar degrees, supporting the notion that
regulatory subunits interact with a structural unit of A and C
subunits. A schematic diagram of the B
deletion and truncation
mutants is shown in Fig.
2A.

View larger version (62K):
[in a new window]
Fig. 2.
Mapping the holoenzyme association
domains of B
by deletion mutagenesis.
Wild-type (w.t.) FLAG-tagged B
, the diagrammed deletion
mutants (A), or vector alone was transiently expressed in
COS-M6 cells, immunoprecipitated (IP), and tested for
association with cotransfected A
subunit (EE epitope-tagged) and
endogenous C subunit by immunoblotting. A representative immunoblot is
shown in B; the broad band below the A
subunit band is
immunoglobulin heavy chain. Coimmunoprecipitated C subunit (C
coIP) was quantified as the ratio of C to B
subunit in each
lane and is listed relative to wild-type B
below the blot (average
of two to four independent experiments).
(
1-20) had little effect on binding to the A and C subunit (Fig.
2B), consistent with a role of these residues in mediating isoform-specific functions. This deletion extends into the predicted first (d)
-strand of WD repeat 1, which, according to the crystal structures of G
1 and p40-ARC, is critical for closure of the
-propeller core by interacting with the c-strand of WD repeat 7 (see
Fig. 1B). It is conceivable that the FLAG epitope tag can substitute for the 5 residues deleted from WD repeat 1; alternatively, the boundaries of this structural motif in B
may require revision.
(
440-447) had no effect on holoenzyme association.
Extending the truncation by just 6 amino acids (
434-447) to include
the predicted c-strand of WD repeat 7 caused an almost complete loss of
A and C subunit binding. Thus, residues 434-439 are required for
holoenzyme association, presumably because they interact with
N-terminal residues to maintain the toroid structure of B
.
protein ranging from 12 to
32 residues in length completely abrogated coimmunoprecipitation of A
and C subunits (3-7% of wild-type); only the
381-401 deletion displayed close to wild-type binding activity (Fig. 2B).
Three of these critical deletions (
128-156,
259-270, and
370-401) are predicted to affect surface-exposed loops connecting
WD repeats, whereas
26-38 deletes a portion of WD repeat 1 predicted to be buried in the protein. The apparent intolerance of the
B
core (residues 21-439) to small deletions suggests that the
interaction of B-family subunits with the AC dimer requires precise
alignment of multiple interacting residues.
residues that were mutated are perfectly conserved in other
mammalian B-family isoforms and their orthologs in worms, fruit flies,
and yeast. Carrying out similar mutagenesis experiments with the A
subunit, we had previously identified charged residues in HEAT repeats
3 (Glu100 and Glu101) and 5 (Arg183) important for binding to regulatory subunits and
viral tumor antigens (42). Hence, we focused the B
mutagenesis on
charge-reversal of basic and acidic residues with the goal of
identifying electrostatic interactions with the A
subunit.
(E66R, EE89RR, and D112K) had no effect on holoenzyme
association (Fig. 3). In contrast, four
B
mutants in WD repeat 3 (RR165EE, D184K, E186R, and DD192RR) and
two mutants in the loop connecting WD repeat 3 and WD repeat 4 (D212K
and IK213EE) displayed severely reduced binding to A and C subunits (between 2% and 12% of wild-type). Mapping to WD repeat 4, B
mutant ED219RR incorporated into the PP2A holoenzyme normally, whereas
E223R was defective. Because B
259-270 was binding-incompetent (Fig. 2B), we tested the effect of mutating all acidic
residues in this region. B
D259R did not bind to the AC dimer,
whereas B
EE266RR, E269R, and D270R had little or no effect on the
ability of B
to associate with A and C subunits. Lastly, the E343R
mutation in WD repeat 6 had an intermediate effect on the ability of
B
to incorporate into the PP2A heterotrimer (40% residual binding of the C subunit; Fig. 3).

View larger version (58K):
[in a new window]
Fig. 3.
Identification of B
residues important for holoenzyme association. A,
wild-type (w.t.) FLAG-tagged B
, the indicated
site-directed mutants, or empty vector was expressed in COS-M6 cells
and tested for association with transfected A
(EE-tagged) and
endogenous C subunits by coimmunoprecipitation (coIP). The
percentage binding of the C subunit was quantified as described in the
Fig. 2 legend and is shown as the average of two to five experiments.
B, summary of B
deletion and site-directed mutagenesis
results. Critical mutations displaying <15% wild-type C subunit
binding activity are indicated on the top of the domain
diagram; noncritical mutations (
40% wild-type binding) are indicated
on the bottom of the domain diagram.
mutants were classified as
critical or noncritical depending on the amount of coimmunoprecipitated C subunit (<15% and
40% of wild-type, respectively). Most critical amino acid substitutions cluster in the middle of the molecule (165-259) encompassing WD repeats 3 and 4.
can bind to the A
subunit in glutathione S-transferase pull-down assays. Intriguingly, the corresponding regions in B
and
B"/PR72 also interacted with A
, even though PP2A regulatory subunit
families display little primary amino acid similarity and are
classified into different structural families according to protein fold
prediction algorithms (39, 47). The N-terminal "A subunit binding
domain" defined by Li and Virshup corresponds to B
residues
172-270, a region that we show here contains many residues necessary
for holoenzyme association in vivo. The C-terminal A subunit
binding domain encompasses B
residues 302-360. We mutated E343 in
this region, which, according to Li and Virshup's domain alignment
(48), is invariant in B, B', B" subunits, and we observed an
intermediate effect on PP2A holoenzyme formation.
interact with residues of opposite charge in A
that we previously
identified as critical for regulatory subunit association
(Glu100, Glu101, and Arg183; Ref.
42). Consequently, we coexpressed charge-reversal mutants of the A
subunit (EE100RR and R183E) with all opposite charge-reversal mutants
of the B
subunit and tested for complementation, i.e. restoration of holoenzyme assembly by coimmunoprecipitation. We were
unable to show association of any of the acidic-to-basic mutants of
B
with the basic-to-acidic mutant A
R183E (data not shown). There
are three potential reasons for this: 1) we may have not mutated the
interacting residue in B
, 2) A
or B
mutations, while
potentially affecting interacting residues, may introduce structural
changes that misalign other important amino acids, and 3) A
R183 may
not interact directly with regulatory subunits.
EE100RR with B
RR165EE, we observed
binding that was comparable to wild-type subunits (Fig.
4). B
RR165EE was unable to
coimmunoprecipitate another binding-defective, acidic-to-basic A
mutant, DW139RR (data not shown), demonstrating that the observed
complementation is not a consequence of altering the overall charge of
the proteins. Thus, PP2A holoenzyme association is critically dependent
on electrostatic interactions between adjacent glutamates in the A
subunit (Glu100 and Glu101 in A
) and
adjacent arginines in B-family regulatory subunits (Arg165
and Arg166 in B
). Because the EE100RR mutation in A
interferes with binding of all regulatory subunit families (42), it is
likely that B' and B" subunits also interact via basic residues. We
reversed the charge of a pair of conserved lysine residues in B'
that is in a position similar to B
Arg165 and Arg166
(B'
KK173DD), but this mutation did not disrupt PP2A holoenzyme assembly (data not shown). Additional studies are necessary to identify
points of contact between A
and B'/B" subunits.

View larger version (42K):
[in a new window]
Fig. 4.
Identification of interacting residues in
B
and A
. Wild-type
(w.t.) or mutant FLAG-tagged B
and EE-tagged A
subunits were coexpressed in the indicated combinations in COS-M6 cells
and tested for association by FLAG immunoprecipitation, followed by
immunoblotting for PP2A subunits.
Is Degraded by the Ubiquitin/proteasome
Pathway--
All B
mutants could be expressed to similar, high
levels in COS-M6 cells, a cell line that supports plasmid replication
due to expression of the SV40 large T antigen. Studying the effects of
B
mutants in the neuronal PC6-3 subline of PC12 cells (49), in which
much lower levels of expression can be achieved, we noticed that
holoenzyme formation-defective mutants could be expressed to at most
10% of wild-type B
levels. This is shown for two mutants in Fig.
5A. Importantly, expression
levels of B
RR165EE, but not D212K, could be rescued by coexpression
of the complementary A
EE100RR mutant, indicating that low
expression is a consequence of failure to incorporate into the PP2A
holoenzyme. To investigate the mechanism of this effect, PC6-3 cells
were treated with the proteasome inhibitor MG-132 for 2 h before
immunoblotting. Proteasome inhibition resulted in a massive increase of
B
protein levels but had no effect on levels of another transfected
protein (calcium/calmodulin-dependent protein kinase II
) or
the endogenous PP2A C subunit (Fig. 5B). MG-132 treatment
led to the accumulation of higher molecular weight species of B
D212K that were immunoreactive for ubiquitin (Fig. 5C).
Similar results were obtained with the RR165EE mutant and wild-type
B
.

View larger version (39K):
[in a new window]
Fig. 5.
Ubiquitination and proteasome-mediated
degradation of monomeric B
subunits in PC6-3 cells.
A, the indicated combinations of wild-type (w.t.)
and mutant B
and A
subunits (ER, EE100RR) were
transiently expressed in PC6-3 cells, and total lysates were
immunoblotted for B
(FLAG tag) and the endogenous C subunit.
B, indicated B
mutants or the
isoform of
calcium/calmodulin-dependent protein kinase II (CaMKII
)
were expressed in PC6-3 cells and treated for 2 h before lysis
without (
) or with (+) the proteasome inhibitor MG-132 (50 µM). Total lysates were immunoblotted for the indicated
proteins. C, FLAG-B
D212K was transfected and
immunoprecipitated from PC6-3 cells treated for 6 h in the absence
or presence of 50 µM MG-132. Aliquots of
immunoprecipitates were blotted for the FLAG tag (left) and
ubiquitin (right). To account for increased levels of B
after MG-132 treatment, twice the volume of the control
immunoprecipitate was analyzed. The distributions of high molecular
weight FLAG tag and ubiquitin immunoreactivities do not correspond well
because of the disproportion of ubiquitin and FLAG epitopes in larger
B
species.
-propeller fold that is found in other proteins engaged in multiple
protein-protein interactions (40, 46). By mutational complementation,
we identified electrostatic interactions between two conserved
arginines in the outer (d) strand of WD repeat 3 of B
and two
glutamates in the intrarepeat loop of HEAT repeat 3 of A
. Previous
domain mapping and site-directed mutagenesis of the A subunit (35, 36,
42) and the present data argue for multiple additional contacts between
regulatory and scaffolding subunits. Also, regulatory subunit binding
to the AC dimer is likely stabilized by direct interactions between B
and C subunits, possibly involving the carboxyl-methylated C terminus
of the C subunit (50-53). Critical amino acids in B
are located
C-terminal of the A subunit-contacting residues Arg165 and
Arg166 and cluster in WD repeats 3 and 4 and the
intervening loop. We propose that this region forms extensive contacts
with the intrarepeat loops of HEAT repeats 4-7 of the A
subunit,
where many residues important for regulatory subunit binding are
localized (42). Consistent with possible isoform-specific functions, we
find that the divergent N-terminal tail of B
is expendable for
intersubunit interactions. Instead, N-terminal residues of B-family
regulatory subunits may determine the subcellular localization of PP2A
holoenzymes by interacting with specific anchoring proteins (19).
Compatible with this view, the B
N terminus faces away from the A
subunit in our PP2A holoenzyme model. This report addresses the
structural basis of PP2A holoenzyme function but requires
ultimate verification and refinement by other methods such as
crystallography.

View larger version (74K):
[in a new window]
Fig. 6.
Model of the PP2A holoenzyme. A
space-filling representation of the structure of the A
subunit (34) is arranged with model structures of the C and B
subunits (based on the PP1 catalytic subunit (38) and G
1 (40),
respectively; see the text). Residues whose mutation disrupts subunit
association (critical) are indicated in black; interacting
residues are colored green. Arg183
(R183) and Trp257 (W257) are
highlighted as representative of several critical residues in HEAT
repeats 5 and 7 of the A
subunit (42). Some critical B
residues
are not shown because they are either absent from the model
(Lys214 and Asp259) or are buried
(Asp192).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Virshup, D. M.
(2000)
Curr. Opin. Cell Biol.
12,
180-185[CrossRef][Medline]
[Order article via Infotrieve]
2.
Janssens, V.,
and Goris, J.
(2001)
Biochem. J.
353,
417-439[CrossRef][Medline]
[Order article via Infotrieve]
3.
Ruediger, R.,
Van Wart Hood, J. E.,
Mumby, M.,
and Walter, G.
(1991)
Mol. Cell. Biol.
11,
4282-4285 4.
Lin, X. H.,
Walter, J.,
Scheidtmann, K.,
Ohst, K.,
Newport, J.,
and Walter, G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14693-14698 5.
Healy, A. M.,
Zolnierowicz, S.,
Stapleton, A. E.,
Goebl, M.,
DePaoli-Roach, A. A.,
and Pringle, J. R.
(1991)
Mol. Cell. Biol.
11,
5767-5780 6.
Mayer, R. E.,
Hendrix, P.,
Cron, P.,
Matthies, R.,
Stone, S. R.,
Goris, J.,
Merlevede, W.,
Hofsteenge, J.,
and Hemmings, B. A.
(1991)
Biochemistry
30,
3589-3597[CrossRef][Medline]
[Order article via Infotrieve]
7.
Pallas, D. C.,
Weller, W.,
Jaspers, S.,
Miller, T. B.,
Lane, W. S.,
and Roberts, T. M.
(1992)
J. Virol.
66,
886-893 8.
Zolnierowicz, S.,
Csortos, C.,
Bondor, J.,
Verin, A.,
Mumby, M. C.,
and DePaoli-Roach, A. A.
(1994)
Biochemistry
33,
11858-11867[CrossRef][Medline]
[Order article via Infotrieve]
9.
Strack, S.,
Chang, D.,
Zaucha, J. A.,
Colbran, R. J.,
and Wadzinski, B. E.
(1999)
FEBS Lett.
460,
462-466[CrossRef][Medline]
[Order article via Infotrieve]
10.
McCright, B.,
and Virshup, D. M.
(1995)
J. Biol. Chem.
270,
26123-26128 11.
McCright, B.,
Rivers, A. M.,
Audlin, S.,
and Virshup, D. M.
(1996)
J. Biol. Chem.
271,
22081-22089 12.
Csortos, C.,
Zolnierowicz, S.,
Bako, E.,
Durbin, S. D.,
and DePaoli-Roach, A. A.
(1996)
J. Biol. Chem.
271,
2578-2588 13.
Tanabe, O.,
Nagase, T.,
Murakami, T.,
Nozaki, H.,
Usui, H.,
Nishito, Y.,
Hayashi, H.,
Kagamiyama, H.,
and Takeda, M.
(1996)
FEBS Lett.
379,
107-111[CrossRef][Medline]
[Order article via Infotrieve]
14.
Tehrani, M. A.,
Mumby, M. C.,
and Kamibayashi, C.
(1996)
J. Biol. Chem.
271,
5164-5170 15.
Zolnierowicz, S.,
Van Hoof, C.,
Andjelkovic, N.,
Cron, P.,
Stevens, I.,
Merlevede, W.,
Goris, J.,
and Hemmings, B. A.
(1996)
Biochem. J.
317,
187-194[Medline]
[Order article via Infotrieve]
16.
Yan, Z.,
Fedorov, S. A.,
Mumby, M. C.,
and Williams, R. S.
(2000)
Mol. Cell. Biol.
20,
1021-1029 17.
Voorhoeve, P. M.,
Hijmans, E. M.,
and Bernards, R.
(1999)
Oncogene
18,
515-524[CrossRef][Medline]
[Order article via Infotrieve]
18.
Hendrix, P.,
Mayer-Jackel, R. E.,
Cron, P.,
Goris, J.,
Hofsteenge, J.,
Merlevede, W.,
and Hemmings, B. A.
(1993)
J. Biol. Chem.
268,
15267-15276 19.
Strack, S.,
Zaucha, J. A.,
Ebner, F. F.,
Colbran, R. J.,
and Wadzinski, B. E.
(1998)
J. Comp. Neurol.
392,
515-527[CrossRef][Medline]
[Order article via Infotrieve]
20.
Pallas, D. C.,
Shahrik, L. K.,
Martin, B. L.,
Jaspers, S.,
Miller, T. B.,
Brautigan, D. L.,
and Roberts, T. M.
(1990)
Cell
60,
167-176[CrossRef][Medline]
[Order article via Infotrieve]
21.
Walter, G.,
Ruediger, R.,
Slaughter, C.,
and Mumby, M.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2521-2525 22.
Sontag, E.,
Fedorov, S.,
Kamibayashi, C.,
Robbins, D.,
Cobb, M.,
and Mumby, M.
(1993)
Cell
75,
887-897[CrossRef][Medline]
[Order article via Infotrieve]
23.
Moreno, C. S.,
Park, S.,
Nelson, K.,
Ashby, D.,
Hubalek, F.,
Lane, W. S.,
and Pallas, D. C.
(2000)
J. Biol. Chem.
275,
5257-5263 24.
Zhao, Y.,
Boguslawski, G.,
Zitomer, R. S.,
and DePaoli-Roach, A. A.
(1997)
J. Biol. Chem.
272,
8256-8262 25.
Silverstein, A. M.,
Barrow, C. A.,
Davis, A. J.,
and Mumby, M. C.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
4221-4226 26.
Turowski, P.,
Myles, T.,
Hemmings, B. A.,
Fernandez, A.,
and Lamb, N. J.
(1999)
Mol. Biol. Cell
10,
1997-2015 27.
Sontag, E.,
Nunbhakdi-Craig, V.,
Bloom, G. S.,
and Mumby, M. C.
(1995)
J. Cell Biol.
128,
1131-1144 28.
Sontag, E.,
Nunbhakdi-Craig, V.,
Lee, G.,
Bloom, G. S.,
and Mumby, M. C.
(1996)
Neuron
17,
1201-1207[CrossRef][Medline]
[Order article via Infotrieve]
29.
Hsu, W.,
Zeng, L.,
and Costantini, F.
(1999)
J. Biol. Chem.
274,
3439-3445 30.
Seeling, J. M.,
Miller, J. R.,
Gil, R.,
Moon, R. T.,
White, R.,
and Virshup, D. M.
(1999)
Science
283,
2089-2091 31.
Kleinberger, T.
(2000)
Apoptosis
5,
211-215[CrossRef][Medline]
[Order article via Infotrieve]
32.
Branton, P. E.,
and Roopchand, D. E.
(2001)
Oncogene
20,
7855-7865[CrossRef][Medline]
[Order article via Infotrieve]
33.
Kamibayashi, C.,
Estes, R.,
Lickteig, R. L.,
Yang, S. I.,
Craft, C.,
and Mumby, M. C.
(1994)
J. Biol. Chem.
269,
20139-20148 34.
Groves, M. R.,
Hanlon, N.,
Turowski, P.,
Hemmings, B. A.,
and Barford, D.
(1999)
Cell
96,
99-110[CrossRef][Medline]
[Order article via Infotrieve]
35.
Ruediger, R.,
Hentz, M.,
Fait, J.,
Mumby, M.,
and Walter, G.
(1994)
J. Virol.
68,
123-129 36.
Ruediger, R.,
Roeckel, D.,
Fait, J.,
Bergqvist, A.,
Magnusson, G.,
and Walter, G.
(1992)
Mol. Cell. Biol.
12,
4872-4882 37.
Egloff, M. P.,
Cohen, P. T.,
Reinemer, P.,
and Barford, D.
(1995)
J. Mol. Biol.
254,
942-959[CrossRef][Medline]
[Order article via Infotrieve]
38.
Goldberg, J.,
Huang, H. B.,
Kwon, Y. G.,
Greengard, P.,
Nairn, A. C.,
and Kuriyan, J.
(1995)
Nature
376,
745-753[CrossRef][Medline]
[Order article via Infotrieve]
39.
Kelley, L. A.,
MacCallum, R. M.,
and Sternberg, M. J.
(2000)
J. Mol. Biol.
299,
499-520[Medline]
[Order article via Infotrieve]
40.
Lambright, D. G.,
Sondek, J.,
Bohm, A.,
Skiba, N. P.,
Hamm, H. E.,
and Sigler, P. B.
(1996)
Nature
379,
311-319[CrossRef][Medline]
[Order article via Infotrieve]
41.
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723[CrossRef][Medline]
[Order article via Infotrieve]
42.
Ruediger, R.,
Fields, K.,
and Walter, G.
(1999)
J. Virol.
73,
839-842 43.
Horowitz, M.,
Cepko, C. L.,
and Sharp, P. A.
(1983)
J. Mol. Appl. Genet.
2,
147-159[Medline]
[Order article via Infotrieve]
44.
Griswold-Prenner, I.,
Kamibayashi, C.,
Maruoka, E. M.,
Mumby, M. C.,
and Derynck, R.
(1998)
Mol. Cell. Biol.
18,
6595-6604 45.
Smith, T. F.,
Gaitatzes, C.,
Saxena, K.,
and Neer, E. J.
(1999)
Trends Biochem. Sci.
24,
181-185[CrossRef][Medline]
[Order article via Infotrieve]
46.
Robinson, R. C.,
Turbedsky, K.,
Kaiser, D. A.,
Marchand, J. B.,
Higgs, H. N.,
Choe, S.,
and Pollard, T. D.
(2001)
Science
294,
1679-1684 47.
Shi, J.,
Blundell, T. L.,
and Mizuguchi, K.
(2001)
J. Mol. Biol.
310,
243-257[CrossRef][Medline]
[Order article via Infotrieve]
48.
Li, X.,
and Virshup, D. M.
(2002)
Eur. J. Biochem.
269,
546-552[Medline]
[Order article via Infotrieve]
49.
Pittman, R. N.,
Wang, S.,
DiBenedetto, A. J.,
and Mills, J. C.
(1993)
J. Neurosci.
13,
3669-3680[Abstract]
50.
Wu, J.,
Tolstykh, T.,
Lee, J.,
Boyd, K.,
Stock, J. B.,
and Broach, J. R.
(2000)
EMBO J.
19,
5672-5681[CrossRef][Medline]
[Order article via Infotrieve]
51.
Tolstykh, T.,
Lee, J.,
Vafai, S.,
and Stock, J. B.
(2000)
EMBO J.
19,
5682-5691[CrossRef][Medline]
[Order article via Infotrieve]
52.
Yu, X. X., Du, X.,
Moreno, C. S.,
Green, R. E.,
Ogris, E.,
Feng, Q.,
Chou, L.,
McQuoid, M. J.,
and Pallas, D. C.
(2001)
Mol. Biol. Cell
12,
185-199 53.
Wei, H.,
Ashby, D. G.,
Moreno, C. S.,
Ogris, E.,
Yeong, F. M.,
Corbett, A. H.,
and Pallas, D. C.
(2001)
J. Biol. Chem.
276,
1570-1577 54.
Bateman, A.,
Birney, E.,
Cerruti, L.,
Durbin, R.,
Etwiller, L.,
Eddy, S. R.,
Griffiths-Jones, S.,
Howe, K. L.,
Marshall, M.,
and Sonnhammer, E. L.
(2002)
Nucleic Acids Res.
30,
276-280
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Batut, B. Schmierer, J. Cao, L. A. Raftery, C. S. Hill, and M. Howell Two highly related regulatory subunits of PP2A exert opposite effects on TGF-{beta}/Activin/Nodal signalling Development, September 1, 2008; 135(17): 2927 - 2937. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kiely, G. S. Baillie, M. J. Lynch, M. D. Houslay, and R. O'Connor Tyrosine 302 in RACK1 Is Essential for Insulin-like Growth Factor-I-mediated Competitive Binding of PP2A and {beta}1 Integrin and for Tumor Cell Proliferation and Migration J. Biol. Chem., August 22, 2008; 283(34): 22952 - 22961. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xia, R. Nho, J. Kleidon, J. Kahm, and C. A. Henke Polymerized Collagen Inhibits Fibroblast Proliferation via a Mechanism Involving the Formation of a {beta}1 Integrin-Protein Phosphatase 2A-Tuberous Sclerosis Complex 2 Complex That Suppresses S6K1 Activity J. Biol. Chem., July 18, 2008; 283(29): 20350 - 20360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Davis, Z. Yan, B. Martinez, and M. C. Mumby Protein Phosphatase 2A Is Targeted to Cell Division Control Protein 6 by a Calcium-binding Regulatory Subunit J. Biol. Chem., June 6, 2008; 283(23): 16104 - 16114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Longin, K. Zwaenepoel, J. V. Louis, S. Dilworth, J. Goris, and V. Janssens Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit J. Biol. Chem., September 14, 2007; 282(37): 26971 - 26980. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Horn, J. Thelu, A. Garcia, C. Albiges-Rizo, M. R. Block, and J. Viallet Functional Interaction of Aurora-A and PP2A during Mitosis Mol. Biol. Cell, April 1, 2007; 18(4): 1233 - 1241. [Abstract] [Full Text] [PDF] |
||||
|
|